Abstract Patients with advanced hepatocellular carcinoma (HCC) have limited treatment options and poor prognosis. This study evaluates the efficacy and safety of a modified BRICS (Bifidobacterium-based probiotics, Radiotherapy, Immunotherapy, and anti-angiogenic therapy with a Stereotactic approach) sequential regimen in a real-world setting.
Yonghai Peng
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yonghai
Contact Yonghai, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack